Herantis Pharma Plc's shares subscribed with option rights
Herantis Pharma Plc, Company release, September 5, 2022 at 8:00 a.m. EEST An aggregate number of 2,400 new shares of Herantis Pharma Plc ("Herantis") have been subscribed for with option rights under the option program 2010. The new shares have been registered with the trade register maintained by the Finnish Patent and Registration Office today. The new shares will confer shareholder rights in Herantis after they have been issued in the book-entry system, on or about 2 September 2022. Trading with the new shares is expected to commence on the Nasdaq First North Growth Market Finland